FDA Inspection 1202500 — Intera Oncology, Inc.
The FDA completed an inspection of Intera Oncology, Inc. on April 5, 2023 in Wellesley, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 5, 2023
- Fiscal Year
- 2023
- Product Type
- Devices
- Project Area
- Postmarket Assurance: Devices
- Location
- Wellesley, MA (United States)